A sports watch shows training load, recovery time, VO₂max, race predictions, and calorie counts, and it builds all of them from an age entered at setup and a wrist sensor. None of it is measured. Each ...
This article is part of a series introducing the latest research in sports science. This time, we cover a study published in ...
This article is part of a series introducing the latest research in sports science one by one. This time, we cover a study ...
A retrospective study used group-based trajectory modeling to show that a steeply rising lactate pattern in neonates with ...
A new study of more than 3,500 critically ill children shows that a simple index combining C-reactive protein with a ...
A controversial blood test aimed at detecting multiple cancers was backed by a U.S. Food and Drug Administration panel this week. On Wednesday, Sept. 23, the FDA's Molecular and Clinical Genetics ...
A U.S. Food and Drug Administration advisory panel voted in favor of recommending that the agency approve a blood test for multiple cancers on Wednesday. The assay, called the Galleri test, is ...
Matthew Herper covers medical innovation — both its promise and its perils. A Food and Drug Administration advisory panel on Wednesday endorsed Galleri, a blood test designed by the biotech firm Grail ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
On August 24, 2026, the U.S. FDA cleared a new single-biomarker blood test to help doctors detect signs of Alzheimer’s disease. The test helps doctors determine both rule-in (positive result) and rule ...
The Food and Drug Administration (FDA) has granted approval for a new test for Alzheimer’s disease, marking the fourth time such a blood test has been approved in less than two years. Roche announced ...
The US Food and Drug Administration has cleared Roche and partner Eli Lilly’s blood test to help identify signs of Alzheimer’s disease in people age ‌55 and older with cognitive decline. The test, ...